I’ve been interested in Rapamycin and Acarbose for a long time (I’m a Peter Attia fan), so I was happy to find Healthspan! Both of those drugs are more targeted at metabolic health by my understanding, but I was wondering if anyone at Healthspan has considered adding protocols for lipid management, since heart health / ASCVD is the other major pillar / risk for most people.
Specifically I’m wondering about things like statins and/or PSK9 inhibitors since they can help lower ApoB. I’m curious—are these on the radar for possible future addition to the platform?